What’s New in Lipid Management to Reduce CV risks and Osteoporosis Update

Learn lastest updates from the Canadian Cardiovascular Society on ways to reduce cardiovascular risk using PCSK9 inhibitors with expert speaker Dr. Peter Lin. There will also be updates on Osteoporosis management.

Key Learning objectives:

• Quick review of the key updates of 2021 CCS lipid guidelines
• Review the MOA, long-term safety and efficacy data for PCSK9i
• Identify patients who would benefit from additional therapy beyond statins to reduce CV risk
• Introduce the new bone formation agent for fracture risk reduction

Date: Wednesday May 17, 2023

Time: 6:30 registration, 7pm presentation

Place: Galineh Restaurant, 900 York Mills Rd

RSVP to chairperson@mtpa.ca with your name, OCP# and practice site